INCYTE HOLDINGS CORP PATENTS FACING OPPOSITIONS
Top patents of INCYTE HOLDINGS CORP facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP2919766B1 | 26 May, 2021 | Sustained-Release Dosage Forms Of Ruxolitinib | Nov, 2033 | 4 | |
| EP3070090B1 | 12 Dec, 2018 | Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile | Jun, 2028 | 1 | |
| EP3050882B1 | 31 Jan, 2018 | Piperidin-4-Yl Azetidine Derivatives As Jak1 Inhibitors | Mar, 2031 | 1 |